Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
Journal of Inherited Metabolic Disease|April 16, 2010
Successful allogeneic bone marrow transplant for Niemann-Pick disease type C2 is likely to be associated with a severe 'graft versus substrate' effectDenise K Bonney, Anne O'Meara, Abdu Shabani, et al.
Journal of Inherited Metabolic Disease|June 22, 2012
Management of mucopolysaccharidosis type IH (Hurler's syndrome) presenting in infancy with severe dilated cardiomyopathy: a single institution's experienceDaniel H Wiseman, Jean Mercer, Karen Tylee, et al.
Bone Marrow Transplantation|May 23, 2006
Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndromeJ Cox-Brinkman, J-J Boelens, J E Wraith, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2006
Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivoAriane Chapgier, Robert F Wynn, Emmanuelle Jouanguy, et al.
Plos One|October 27, 2011
Female mucopolysaccharidosis IIIA mice exhibit hyperactivity and a reduced sense of danger in the open field testAlex Langford-Smith, Kia J Langford-Smith, Simon A Jones, et al.
Blood|July 15, 2004
A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrowRobert F Wynn, Claire A Hart, Carla Corradi-Perini, et al.
Biogerontology|November 8, 2008
Telomere length dynamics differ in foetal and early post-natal human leukocytes in a longitudinal studyDenise K Holmes, Ilaria Bellantuono, Steve A Walkinshaw, et al.
Blood Advances|February 22, 2019
Immune cytopenia post-cord transplant in Hurler syndrome is a forme fruste of graft rejectionDavid Deambrosis, Su Han Lum, Ryan M Hum, et al.
Plos One|October 23, 2013
Signal one and two blockade are both critical for non-myeloablative murine HSCT across a major histocompatibility complex barrierKia J Langford-Smith, Zara Sandiford, Alex Langford-Smith, et al.
Pediatric Transplantation|December 30, 2014
In vivo T-cell depletion using alemtuzumab in family and unrelated donor transplantation for pediatric non-malignant disease achieves engraftment with low incidence of graft vs. host diseaseM A Saif, R Borrill, B W Bigger, et al.
Pageof 11